Literature DB >> 25061168

Erythroid mRNA processing: a "splice of life".

Don M Wojchowski1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25061168      PMCID： PMC4110652          DOI： 10.1182/blood-2014-06-579649

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Alternative splicing: a pivotal step between eukaryotic transcription and translation.

Authors:  Alberto R Kornblihtt; Ignacio E Schor; Mariano Alló; Gwendal Dujardin; Ezequiel Petrillo; Manuel J Muñoz
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-06       Impact factor: 94.444

Review 2.  Ndel1, Nudel (Noodle): flexible in the cell?

Authors:  Mathieu Chansard; Ji-Ho Hong; Young-Un Park; Sang Ki Park; Minh Dang Nguyen
Journal:  Cytoskeleton (Hoboken)       Date:  2011-10-04

3.  Global transcriptome analyses of human and murine terminal erythroid differentiation.

Authors:  Xiuli An; Vincent P Schulz; Jie Li; Kunlu Wu; Jing Liu; Fumin Xue; Jingping Hu; Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2014-03-17       Impact factor: 22.113

4.  Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis.

Authors:  Albert W Cheng; Jiahai Shi; Piu Wong; Katherine L Luo; Paula Trepman; Eric T Wang; Heejo Choi; Christopher B Burge; Harvey F Lodish
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

5.  FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

Authors:  L Sehgal; R Mathur; F K Braun; J F Wise; Z Berkova; S Neelapu; L W Kwak; F Samaniego
Journal:  Leukemia       Date:  2014-04-03       Impact factor: 11.528

6.  Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.

Authors:  Eric T Wang; Neal A L Cody; Sonali Jog; Michela Biancolella; Thomas T Wang; Daniel J Treacy; Shujun Luo; Gary P Schroth; David E Housman; Sita Reddy; Eric Lécuyer; Christopher B Burge
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

Review 7.  The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.

Authors:  Maya Pascual; Marta Vicente; Lidon Monferrer; Ruben Artero
Journal:  Differentiation       Date:  2006-03       Impact factor: 3.880

Review 8.  The spliceosome as a target of novel antitumour drugs.

Authors:  Sophie Bonnal; Luisa Vigevani; Juan Valcárcel
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

9.  MBNL proteins repress ES-cell-specific alternative splicing and reprogramming.

Authors:  Hong Han; Manuel Irimia; P Joel Ross; Hoon-Ki Sung; Babak Alipanahi; Laurent David; Azadeh Golipour; Mathieu Gabut; Iacovos P Michael; Emil N Nachman; Eric Wang; Dan Trcka; Tadeo Thompson; Dave O'Hanlon; Valentina Slobodeniuc; Nuno L Barbosa-Morais; Christopher B Burge; Jason Moffat; Brendan J Frey; Andras Nagy; James Ellis; Jeffrey L Wrana; Benjamin J Blencowe
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

10.  Compound loss of muscleblind-like function in myotonic dystrophy.

Authors:  Kuang-Yung Lee; Moyi Li; Mini Manchanda; Ranjan Batra; Konstantinos Charizanis; Apoorva Mohan; Sonisha A Warren; Christopher M Chamberlain; Dustin Finn; Hannah Hong; Hassan Ashraf; Hideko Kasahara; Laura P W Ranum; Maurice S Swanson
Journal:  EMBO Mol Med       Date:  2013-10-08       Impact factor: 12.137
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.